Chronic News and Research

RSS

University of Minnesota, Mayo Clinic form strategic research relationship with Karolinska Institute

The University of Minnesota and Mayo Clinic, under the mantle of the Minnesota Partnership for Biotechnology and Medical Genomics, have formed a strategic research relationship with the Karolinska Institute of Stockholm, Sweden, the top-rated medical research university in Europe. Leaders of each institution signed memoranda of understanding to commit to the formal ongoing collaboration, called the Frontiers of Biomedical Research.

2 Jun 2010

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

VIVUS, Inc. today announced that data from the previously reported phase 3 pivotal REVIVE (TA-301) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED), were presented at the American Urological Association (AUA) 2010 Annual Meeting.

2 Jun 2010

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

In addition to their suffering, rare disease patients often have to face the harsh reality that few pharmaceutical companies will ever be able to offer new treatments for their condition because the costs of new treatments will never be recovered from such a small market. But there are ways they can be helped. The U.S. Food and Drug Administration's "Orphan Drug Designation" offers a wide range of benefits that help organizations developing treatments for diseases and conditions affecting fewer than 200,000 patients in the United States.

2 Jun 2010

Medicare patients may face accessibility crisis to medical care

According to an article in the June issue of the Journal of Bone and Joint Surgery (JBJS), Medicare patients - many who suffer from disabling arthritis of the hip and knee, among other age-related ailments - may end up facing an accessibility crisis to medical care.

2 Jun 2010

Enrollment and dosing in NeuroDerm's Phase I clinical trial of ND0611 completed

NeuroDerm, Ltd. announced today the successful enrollment and dosing in its Phase I clinical trial of ND0611. ND0611, a proprietary drug formula administered via a dermal patch, is designed to maintain continuous therapeutic levodopa concentrations for improving the treatment of Parkinson's disease.

1 Jun 2010

Centocor Ortho Biotech acquires RespiVert

Centocor Ortho Biotech Inc. today announced that it has acquired RespiVert Ltd., a privately held drug discovery company focused on developing small-molecule, inhaled therapies for the treatment of pulmonary diseases. The company's lead compounds, RV-568 and RV-1088, narrow spectrum kinase inhibitors with a unique profile of anti-inflammatory activities, are progressing into clinical development as potential first-in-class treatments for moderate to severe asthma, Chronic Obstructive Pulmonary Disease (COPD) and Cystic Fibrosis (CF).

1 Jun 2010

OroScience signs agreement with ACE Surgical Supply to market Periogenix periodontal wound dressing

OroScience plc (Palo Alto, CA), an oral care life science company, announced today that it has entered into an agreement with ACE Surgical Supply, Inc. (Brockton, MA) to market and distribute Periogenix periodontal wound dressing to clinicians in the United States and Canadian dental markets.

1 Jun 2010

Foods advertised on TV oversupply nutrients associated with chronic illness: Study

Making food choices based on television advertising results in a very imbalanced diet according to a new study comparing the nutritional content of food choices influenced by television to nutritional guidelines published in the June issue of the Journal of the American Dietetic Association.

1 Jun 2010

Canadian Diabetes Association supports TELUS Health Solutions' new online consumer ehealth service

Access to relevant health information is crucial when it comes to successful diabetes management. The Canadian Diabetes Association is pleased to support TELUS Health Solutions' launch of TELUS health space - an innovative new online consumer health service for Canadians and their healthcare providers

1 Jun 2010

Hepatitis C investigations intensify as number of women infected by doctor rises

In recent news 12 women had been infected with the Hepatitis C virus allegedly from an anaesthetist Dr James Latham Peters, practising at an abortion clinic, Croydon Day Surgery. As the investigations continue the number of infected women has risen to 44.

1 Jun 2010

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

Results of a subanalysis from the FAIR-HF study demonstrate that correcting iron deficiency with Ferinject (ferric carboxymaltose) can improve renal function in chronic heart failure patients. Ferinject is an intravenous iron product used to treat iron deficiency and iron deficiency anaemia.

From CSL Ltd 31 May 2010

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

On the verge of a BC Government announcement on a new policy on generic medication pricing and a Long Term Pharmacy Agreement, the Better Pharmacare Coalition (BPC) is mobilizing its two million members to ensure Government keeps its promise that patient interests and input are reflected in the new BC PharmaCare drug review process.

31 May 2010

Secretary of Health commends two Allegheny County schools for commitment to exercise every day

Secretary of Health Everette James today visited the Avonworth and Mt. Royal middle schools in Allegheny County to commend students and teachers for their yearlong commitment to exercising for 30 minutes every school day.

29 May 2010

HHS awards $15M to create new center for health information and privacy at University of Illinois

Slowly but steadily the U.S. health care community is moving into the digital age: shifting their medical records from paper to electronic information systems. This movement raises serious concerns about security and privacy of patients' medical information. In an attempt to put these concerns to rest, the U.S. Department of Health and Human Services has awarded $15 million to create a new center for health information and privacy.

29 May 2010

Anthem supports over 60 of Maine's caring non-profit agencies

The American Diabetes Association, Aroostook Mental Health Services, and the Wellness Council of Maine were among more than 60 non-profit agencies across the state that Anthem Blue Cross and Blue Shield in Maine supported during 2009.

29 May 2010

Famous painters, musicians, and writers who fought against neurological disorders

The third part of Neurological Disorders in Famous Artists presents painters, musicians, and writers who had to fight against an acute or chronic neurological disease. Sometimes this fight was without success (e.g. Shostakovich, Schumann, Wolf, Pascal), but often a dynamic and paradoxical creativity of the clinical disorder was integrated into their artistic production (e.g. Klee, Ramuz).

29 May 2010

ICA hosts forum to improve quality of healthcare and lives of people with IC

The Interstitial Cystitis Association is hosting a forum and interactive webcast on Saturday, June 5, 2010 at the Hutton Hotel in Nashville. The event, "Finding Better Relief: Working with an IC Healthcare Team", gives interstitial cystitis patients the opportunity to learn about innovative treatment approaches from top IC doctors.

29 May 2010

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

Bioheart, Inc., announced today plans for establishing two Centers of Excellence in the Middle East to provide its cell therapy procedures to patients suffering from congestive heart failure and peripheral arterial disease. Dr. Karl E. Groth, Chairman and CEO, and Peggy A. Farley, Chief Operating and Financial Officer, are now in that region holding discussions and performing site inspections.

29 May 2010

CytRx commences Phase 2 clinical trial of bafetinib for high-risk B-cell chronic lymphocytic leukemia

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of a Phase 2 proof-of-concept clinical trial to evaluate the preliminary efficacy and safety of its oncology drug candidate bafetinib in patients with high-risk B-cell chronic lymphocytic leukemia (B-CLL).

29 May 2010

DFG approves establishment of twelve new CRCs

The Deutsche Forschungsgemeinschaft has approved the establishment of twelve new Collaborative Research Centres beginning 1 July 2010. This was decided by the responsible Grants Committee at its spring meeting in Bonn. The new CRCs will initially be funded for four years with a total of 112 million euros (including a 20% programme allowance for indirect project costs).

29 May 2010

Chronic News and Research

University of Minnesota, Mayo Clinic form strategic research relationship with Karolinska Institute

Phase 3 pivotal REVIVE study data of VIVUS' avanafil for ED presented at 2010 AUA

McGill University granted 'Orphan Drug Designation' for pulmonary infection drug fenretinide

Medicare patients may face accessibility crisis to medical care

Enrollment and dosing in NeuroDerm's Phase I clinical trial of ND0611 completed

Centocor Ortho Biotech acquires RespiVert

OroScience signs agreement with ACE Surgical Supply to market Periogenix periodontal wound dressing

Foods advertised on TV oversupply nutrients associated with chronic illness: Study

Canadian Diabetes Association supports TELUS Health Solutions' new online consumer ehealth service

Hepatitis C investigations intensify as number of women infected by doctor rises

FAIR-HF study: Ferinject improves renal function in patients with CHF and iron deficiency

BPC mobilizes to ensure patient interests are put first in new BC PharmaCare drug review process

Secretary of Health commends two Allegheny County schools for commitment to exercise every day

HHS awards $15M to create new center for health information and privacy at University of Illinois

Anthem supports over 60 of Maine's caring non-profit agencies

Famous painters, musicians, and writers who fought against neurological disorders

ICA hosts forum to improve quality of healthcare and lives of people with IC

Bioheart to establish two Centers of Excellence to provide cell therapy procedures for patients with CHF, PAD

CytRx commences Phase 2 clinical trial of bafetinib for high-risk B-cell chronic lymphocytic leukemia

DFG approves establishment of twelve new CRCs

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News